Figures & data
Table 1. Mean and median scores for age, IQ, RM2000 (sexual), RM2000 (violent) and SARN across experimental and comparison samples.
Table 2. Descriptive statistics for clinical measures and correlation with Sexual Compulsivity.
Figure 1. Mean sexual compulsivity scores for participants taking (i) Anti-Androgens (n = 8), (ii) Selective-serotonin reuptake inhibitors (n = 69) and (iii) no medication (n = 58) pre-medication and three months post-medication.
![Figure 1. Mean sexual compulsivity scores for participants taking (i) Anti-Androgens (n = 8), (ii) Selective-serotonin reuptake inhibitors (n = 69) and (iii) no medication (n = 58) pre-medication and three months post-medication.](/cms/asset/0c355657-10b4-42fb-b2a8-d5763ff157fe/rjfp_a_2338917_f0001_oc.jpg)
Figure 2. Frequencies of participants below and above cut offs (≥1.5 and >2.1) for sexual compulsivity pre-medication and (three months) post-medication for (i) Anti-Androgens (n = 8), (ii) Selective-Serotonin Reuptake Inhibitors (n = 72) and (iii) no medication (n = 58) pre-medication and three months post-medication.
![Figure 2. Frequencies of participants below and above cut offs (≥1.5 and >2.1) for sexual compulsivity pre-medication and (three months) post-medication for (i) Anti-Androgens (n = 8), (ii) Selective-Serotonin Reuptake Inhibitors (n = 72) and (iii) no medication (n = 58) pre-medication and three months post-medication.](/cms/asset/ad2b8222-f3c3-4bc5-a4ae-3a62b4f3e12d/rjfp_a_2338917_f0002_oc.jpg)